S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.68 (+0.22%)
AAPL   191.00 (+0.55%)
MSFT   374.67 (-1.12%)
META   324.95 (-0.67%)
GOOGL   131.51 (-0.77%)
AMZN   147.02 (+0.64%)
TSLA   237.85 (-0.93%)
NVDA   467.15 (-0.12%)
NIO   7.20 (-0.96%)
BABA   73.90 (-1.31%)
AMD   121.07 (-0.07%)
T   16.69 (+0.72%)
F   10.58 (+3.12%)
MU   75.78 (-0.45%)
CGC   0.62 (+10.77%)
GE   122.91 (+0.91%)
DIS   92.34 (-0.38%)
AMC   6.88 (+3.46%)
PFE   28.75 (-5.64%)
PYPL   59.50 (+3.28%)
XOM   102.98 (+0.23%)
S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.68 (+0.22%)
AAPL   191.00 (+0.55%)
MSFT   374.67 (-1.12%)
META   324.95 (-0.67%)
GOOGL   131.51 (-0.77%)
AMZN   147.02 (+0.64%)
TSLA   237.85 (-0.93%)
NVDA   467.15 (-0.12%)
NIO   7.20 (-0.96%)
BABA   73.90 (-1.31%)
AMD   121.07 (-0.07%)
T   16.69 (+0.72%)
F   10.58 (+3.12%)
MU   75.78 (-0.45%)
CGC   0.62 (+10.77%)
GE   122.91 (+0.91%)
DIS   92.34 (-0.38%)
AMC   6.88 (+3.46%)
PFE   28.75 (-5.64%)
PYPL   59.50 (+3.28%)
XOM   102.98 (+0.23%)
S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.68 (+0.22%)
AAPL   191.00 (+0.55%)
MSFT   374.67 (-1.12%)
META   324.95 (-0.67%)
GOOGL   131.51 (-0.77%)
AMZN   147.02 (+0.64%)
TSLA   237.85 (-0.93%)
NVDA   467.15 (-0.12%)
NIO   7.20 (-0.96%)
BABA   73.90 (-1.31%)
AMD   121.07 (-0.07%)
T   16.69 (+0.72%)
F   10.58 (+3.12%)
MU   75.78 (-0.45%)
CGC   0.62 (+10.77%)
GE   122.91 (+0.91%)
DIS   92.34 (-0.38%)
AMC   6.88 (+3.46%)
PFE   28.75 (-5.64%)
PYPL   59.50 (+3.28%)
XOM   102.98 (+0.23%)
S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.68 (+0.22%)
AAPL   191.00 (+0.55%)
MSFT   374.67 (-1.12%)
META   324.95 (-0.67%)
GOOGL   131.51 (-0.77%)
AMZN   147.02 (+0.64%)
TSLA   237.85 (-0.93%)
NVDA   467.15 (-0.12%)
NIO   7.20 (-0.96%)
BABA   73.90 (-1.31%)
AMD   121.07 (-0.07%)
T   16.69 (+0.72%)
F   10.58 (+3.12%)
MU   75.78 (-0.45%)
CGC   0.62 (+10.77%)
GE   122.91 (+0.91%)
DIS   92.34 (-0.38%)
AMC   6.88 (+3.46%)
PFE   28.75 (-5.64%)
PYPL   59.50 (+3.28%)
XOM   102.98 (+0.23%)

Can-Fite BioPharma (CANF) Earnings Date, Estimates & Call Transcripts

$2.45
+0.10 (+4.26%)
(As of 02:35 PM ET)
Compare
Today's Range
$2.31
▼
$2.46
50-Day Range
$1.90
▼
$2.65
52-Week Range
$1.52
▼
$8.40
Volume
23,107 shs
Average Volume
61,665 shs
Market Capitalization
$8.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Latest
Earnings Date
Aug. 31Estimated
Actual EPS
(Aug. 31)
-$0.40 Beat By $0.14
Consensus EPS
(Aug. 31)
-$0.54
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CANF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CANF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Can-Fite BioPharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20231($0.43)($0.43)($0.43)
Q4 20231($0.43)($0.43)($0.43)

CANF Earnings Date and Information

Can-Fite BioPharma last released its quarterly earnings data on August 31st, 2023. The reported ($0.40) EPS for the quarter, topping the consensus estimate of ($0.54) by $0.14. The company earned $0.20 million during the quarter, compared to analysts' expectations of $0.20 million. Can-Fite BioPharma has generated ($3.06) earnings per share over the last year (($3.06) diluted earnings per share). Earnings for Can-Fite BioPharma are expected to grow in the coming year, from ($1.92) to ($0.59) per share.

Can-Fite BioPharma Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/31/2023Q2 2023($0.54)($0.40)+$0.14($0.40)$0.20 million$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
6/1/2023Q1 2023-($0.65)($0.65)($0.65)-$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
3/30/2023Q4 2022($0.57)($1.11)($0.54)($1.11)$0.50 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
11/25/2022Q3 2022($1.00)($0.90)+$0.10($0.90)$0.40 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.80)$0.30 million$0.20 million
8/25/2022Q2 2022($0.09)($0.08)+$0.01($0.08)$0.30 million$0.20 million
8/25/2022Q2 2022($0.90)($0.80)+$0.10($0.08)$0.30 million$0.20 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.90)$0.20 million$0.21 million
5/26/2022Q1 2022($1.20)($0.90)+$0.30($0.09)$0.20 million$0.21 million
5/26/2022Q1 2022($0.12)($0.09)+$0.03($0.09)$0.20 million$0.21 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($1.90)$0.30 million$0.20 million
3/24/2022Q4 2021($0.18)($0.19)($0.01)($0.19)$0.30 million$0.20 million
3/24/2022Q4 2021($1.80)($1.90)($0.10)($0.19)$0.30 million$0.20 million
11/30/2021Q3 2021($0.90)($1.90)($1.00)($0.19)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($1.00)($1.90)($0.90)($1.90)-$0.25 million
11/26/2021Q3 2021($0.10)($0.19)($0.09)($0.19)-$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($1.90)$0.30 million$0.25 million
8/26/2021Q2 2021($0.12)($0.19)($0.07)($0.19)$0.30 million$0.25 million
8/26/2021Q2 2021($1.20)($1.90)($0.70)($0.19)$0.30 million$0.25 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($1.20)$0.30 million$0.15 million
5/27/2021Q1 2021($0.17)($0.12)+$0.05($0.12)$0.30 million$0.15 million
5/27/2021Q1 2021($1.70)($1.20)+$0.50($0.12)$0.30 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($3.00)$0.50 million$0.15 million
3/25/2021Q4 2020($0.13)($0.30)($0.17)($0.30)$0.50 million$0.15 million
3/25/2021Q4 2020($1.30)($3.00)($1.70)($0.30)$0.50 million$0.15 million












Can-Fite BioPharma Earnings - Frequently Asked Questions

When did Can-Fite BioPharma announce their last quarterly earnings?

Can-Fite BioPharma (NYSE:CANF) last announced its quarterly earning data on Thursday, August 31, 2023. Learn more on CANF's earnings history.

Did Can-Fite BioPharma beat their earnings estimates last quarter?

In the previous quarter, Can-Fite BioPharma (NYSE:CANF) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.14. Learn more on analysts' earnings estimate vs. CANF's actual earnings.

How much revenue does Can-Fite BioPharma generate each year?

Can-Fite BioPharma (NYSE:CANF) has a recorded annual revenue of $810,000.00.

How much profit does Can-Fite BioPharma generate each year?

Can-Fite BioPharma (NYSE:CANF) has a recorded net income of -$10.17 million. CANF has generated -$3.06 earnings per share over the last four quarters.

What is Can-Fite BioPharma's EPS forecast for next year?

Can-Fite BioPharma's earnings are expected to grow from ($1.92) per share to ($0.59) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:CANF) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -